Connect Biopharma Holdings Limited

Connect Biopharma Holdings Limitedverified

CNTB

Price:

$1.78

Market Cap:

$98.08M

Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, focuses on the discovery and development of immune modulators for the treatment of serious autoimmune diseases and inflammation. The company's lead product candidate is CBP-201, an anti-interleukin-4 receptor alpha antibody, which is in Phase IIb clinical trial for the treatment of inflammatory allergic diseases, such as atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyps. Its products also comprise CBP-307, a small molecule modulator of sphingosine 1-phosphate receptor 1, a regulator of T cell mobilization out of lymph nodes into the periphery that is in Phase II for the treatment of autoimmu...[Read more]

Industry

Biotechnology

IPO Date

2021-03-19

Stock Exchange

NASDAQ

Ticker

CNTB

The PE Ratio as of May 2024 (TTM) for Connect Biopharma Holdings Limited (CNTB) is -1.65

According to Connect Biopharma Holdings Limited’s latest financial reports and current stock price. The company's current PE Ratio is -1.65. This represents a change of -43.36% compared to the average of -2.91 of the last 4 quarters.

Connect Biopharma Holdings Limited (CNTB) Historical PE Ratio (quarterly & annually)

How has CNTB PE Ratio performed in the past?

The mean historical PE Ratio of Connect Biopharma Holdings Limited over the last ten years is -10.68. The current -1.65 PE Ratio has changed 1.45% with respect to the historical average. Over the past ten years (40 quarters), CNTB's PE Ratio was at its highest in in the December 2020 quarter at 0. The PE Ratio was at its lowest in in the March 2023 quarter at -6.13.

Quarterly (TTM)
Annual

Average

-10.68

Median

-1.31

Minimum

-43.38

Maximum

0

Connect Biopharma Holdings Limited (CNTB) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Connect Biopharma Holdings Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 0%

Maximum Annual PE Ratio = 0

Minimum Annual Increase = -100.00%

Minimum Annual PE Ratio = -43.38

Quarterly (TTM)
Annual
YearPE RatioChange
20230-100.00%
2022-0.41-68.49%
2021-1.31-84.19%
2020-8.29-80.89%

Connect Biopharma Holdings Limited (CNTB) Average PE Ratio

How has CNTB PE Ratio performed in the past?

The current PE Ratio of Connect Biopharma Holdings Limited (CNTB) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-0.57

5-year avg

-10.68

10-year avg

-10.68

Connect Biopharma Holdings Limited (CNTB) PE Ratio vs. Peers

How is CNTB’s PE Ratio compared to its peers?

Connect Biopharma Holdings Limited’s PE Ratio is less than Assembly Biosciences, Inc. (0), less than Neoleukin Therapeutics, Inc. (-1.55), less than Instil Bio, Inc. (-0.98), less than CytomX Therapeutics, Inc. (-0.61), less than Achilles Therapeutics plc (9.38), less than NextCure, Inc. (-0.59), less than Nuvation Bio Inc. (-0.73), greater than Ovid Therapeutics Inc. (-10.56), greater than null (-4.40),

Build a custom stock screener for Connect Biopharma Holdings Limited (CNTB) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Connect Biopharma Holdings Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Connect Biopharma Holdings Limited (CNTB) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Connect Biopharma Holdings Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Connect Biopharma Holdings Limited's PE Ratio?

How is the PE Ratio calculated for Connect Biopharma Holdings Limited (CNTB)?

What is the highest PE Ratio for Connect Biopharma Holdings Limited (CNTB)?

What is the 3-year average PE Ratio for Connect Biopharma Holdings Limited (CNTB)?

What is the 5-year average PE Ratio for Connect Biopharma Holdings Limited (CNTB)?

How does the current PE Ratio for Connect Biopharma Holdings Limited (CNTB) compare to its historical average?